| Reaction Details |
|---|
 | Report a problem with these data |
| Target | 5-hydroxytryptamine receptor 1F |
|---|
| Ligand | BDBM50106482 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2085 (CHEMBL616728) |
|---|
| Ki | 8.20±n/a nM |
|---|
| Citation |  Xu, YC; Johnson, KW; Phebus, LA; Cohen, M; Nelson, DL; Schenck, K; Walker, CD; Fritz, JE; Kaldor, SW; LeTourneau, ME; Murff, RE; Zgombick, JM; Calligaro, DO; Audia, JE; Schaus, JM N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy. J Med Chem44:4031-4 (2001) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| 5-hydroxytryptamine receptor 1F |
|---|
| Name: | 5-hydroxytryptamine receptor 1F |
|---|
| Synonyms: | 5-HT-1F | 5-HT1F | 5-hydroxytryptamine receptor 1F | 5HT1F_HUMAN | HTR1EL | HTR1F | Serotonin (5-HT) receptor | Serotonin 1f (5-HT1f) receptor | Serotonin receptor 1F |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 41724.68 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | 5-HT1F HTR1F HUMAN::P30939 |
|---|
| Residue: | 366 |
|---|
| Sequence: | MDFLNSSDQNLTSEELLNRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANY
LICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQVVCDIWLSVDITCCTCSILHLSAIALD
RYRAITDAVEYARKRTPKHAGIMITIVWIISVFISMPPLFWRHQGTSRDDECIIKHDHIV
STIYSTFGAFYIPLALILILYYKIYRAAKTLYHKRQASRIAKEEVNGQVLLESGEKSTKS
VSTSYVLEKSLSDPSTDFDKIHSTVRSLRSEFKHEKSWRRQKISGTRERKAATTLGLILG
AFVICWLPFFVKELVVNVCDKCKISEEMSNFLAWLGYLNSLINPLIYTIFNEDFKKAFQK
LVRCRC
|
|
|
|---|
| BDBM50106482 |
|---|
| n/a |
|---|
| Name | BDBM50106482 |
|---|
| Synonyms: | CHEMBL339980 | N-[3-(2-Dimethylamino-ethyl)-2-methyl-1H-indol-4-yl]-4-fluoro-benzamide |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C20H22FN3O |
|---|
| Mol. Mass. | 339.4066 |
|---|
| SMILES | CN(C)CCc1c(C)[nH]c2cccc(NC(=O)c3ccc(F)cc3)c12 |
|---|
| Structure | 
|
|---|
Search and Browse
